CDK8-IN-11 is a selective and potent CDK8 inhibitor that shows antiproliferative activity in colon cancer cell lines, inhibiting WNT/beta-catenin activation and TCF family transcriptional activity, inducing G1-phase arrest in HCT-116 cells, useful for colon cancer research.
Molekulargewicht:
388.34
Reinheit:
99.74%
CAS Nummer:
[2839338-28-0]
Formel:
C19H15F3N4O2
Target-Kategorie:
Wnt/beta-catenin|||CDK
T61742
T61742
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten